DS-3201b and Irinotecan for Patients With Recurrent Small Cell Lung Cancer
Clinical trial NCT03879798 · TERMINATED
Trial details
- NCT number
- NCT03879798
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-15
- Primary completion
- 2023-05-02
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.